Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

NCT04402385 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04402385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04402385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Terminated
Start date
August 6, 2020
Completion date
June 22, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated blood pressure, pre-eclampsia, stage 1 hypertension